α-thalassaemia
-
Clinical News
PYRUVATE KINASE DEFICIENCY | FDA Approves First Drug For The Rare Inherited Anemia
The US Food and Drug Administration (FDA) has announced the approval of Mitapivat (PYRUKYND®) tablets as treatment for haemolytic anemia in adults with pyruvate kinase (PK) deficiency. The oral PK…
Weiterlesen » -
TIF Publications
Beta Thalassaemia, Alpha Thalassaemia and Sickle Cell Disease Educational Community booklet (2014)
Eleftheriou A, Angastiniotis M English Greek
Weiterlesen »